Want to see SG:T14 full AI Analyst Report?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Financial Statements
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Financial Overview
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's market cap is currently $3.96B. The company's EPS TTM is $1.10; its P/E ratio is 36.55; and it has a dividend yield of 26.76%. Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.92B | $ 7.31B | $ 8.22B | $ 8.25B | $ 6.91B |
| Gross Profit | $ 3.64B | $ 3.52B | $ 3.62B | $ 3.29B | $ 2.76B |
| Operating Income | $ 2.49B | $ 2.57B | $ 1.10B | $ 980.05M | $ 866.68M |
| EBITDA | $ 2.61B | $ 2.74B | $ 1.26B | $ 1.11B | $ 991.28M |
| Net Income | $ 2.13B | $ 2.23B | $ 986.71M | $ 861.79M | $ 769.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.02B | $ 3.94B | $ 2.15B | $ 2.88B | $ 2.28B |
| Total Assets | $ 11.69B | $ 10.77B | $ 10.23B | $ 10.16B | $ 9.07B |
| Total Debt | $ 62.56M | $ 27.26M | $ 325.58M | $ 257.91M | $ 33.17M |
| Net Debt | $ -953.87M | $ -2.92B | $ -1.80B | $ -2.62B | $ -2.25B |
| Total Liabilities | $ 4.59B | $ 2.92B | $ 3.58B | $ 3.61B | $ 2.55B |
| Stockholders' Equity | $ 7.10B | $ 7.84B | $ 6.60B | $ 6.52B | $ 6.36B |
| Cash Flow | |||||
| Free Cash Flow | $ 342.45M | $ 806.86M | $ 547.56M | $ 569.34M | $ 695.45M |
| Operating Cash Flow | $ 461.07M | $ 924.67M | $ 688.49M | $ 677.25M | $ 852.40M |
| Investing Cash Flow | $ -1.41B | $ 342.31M | $ -744.21M | $ -12.28M | $ -311.85M |
| Financing Cash Flow | $ -980.88M | $ -319.89M | $ -836.65M | $ -236.62M | $ -244.70M |
Currency in CNY
